Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis

Giovanni D'Arena, G. Rossi, M. M. Minervini, L. Savino, F. D'Auria, L. Laurenti, M. I. Del Principe, S. Deaglio, A. Biagi, L. De Martino, V. De Feo, T. Statuto, P. Musto, G. Del Poeta

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Regulatory T-cells (Tregs) constitute a small subset of cells involved in antitumour immunity and are generally increased in patients with chronic lymphocytic leukemia (CLL). No data is available on Tregs in monoclonal B-cell lymphocytosis (MBL), a disease entity characterized by less than 5000/μL circulating clonal B-cells in absence of other features of lymphoproliferative disorders. We used multicolour flow cytometry to evaluate the number of circulating Tregs in 56 patients with "clinical" MBL, 74 patients with previously untreated CLL and 40 healthy subjects. MBL patients showed a lower absolute number of Tregs, compared to CLL patients, but slightly higher than controls. Moreover, the absolute cell number of Tregs directly correlated both with more advanced Rai/Binet clinical stages and peripheral blood B-cell lymphocytosis. Of note, the absolute number of Tregs was found lower in MBL patients than in CLL patients staged as 0/A Rai/Binet. The study showed that Tregs increase gradually from normal subjects to "clinical" MBL patients and are significantly higher in CLL patients as compared to MBL patients. Moreover, a significant direct relationship was found between higher Treg values and a higher tumor burden expressed by B-lymphocytosis or more advanced clinical stages. In light of this data, MBL seems to be a preliminary phase preceding CLL. The progressive increase of Treg numbers might contribute both to the clinical evolution of MBL to overt CLL and to CLL progression.

Original languageEnglish
Pages (from-to)915-923
Number of pages9
JournalInternational Journal of Immunopathology and Pharmacology
Volume24
Issue number4
Publication statusPublished - Oct 2011

Fingerprint

Lymphocytosis
Regulatory T-Lymphocytes
B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
Lymphoproliferative Disorders
Tumor Burden
Immunity
Blood Cells
Healthy Volunteers
Flow Cytometry
Cell Count

Keywords

  • Chronic lymphocytic leukemia
  • Monoclonal B-cell lymphocytosis
  • Regulatory T cells

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy

Cite this

D'Arena, G., Rossi, G., Minervini, M. M., Savino, L., D'Auria, F., Laurenti, L., ... Del Poeta, G. (2011). Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis. International Journal of Immunopathology and Pharmacology, 24(4), 915-923.

Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis. / D'Arena, Giovanni; Rossi, G.; Minervini, M. M.; Savino, L.; D'Auria, F.; Laurenti, L.; Del Principe, M. I.; Deaglio, S.; Biagi, A.; De Martino, L.; De Feo, V.; Statuto, T.; Musto, P.; Del Poeta, G.

In: International Journal of Immunopathology and Pharmacology, Vol. 24, No. 4, 10.2011, p. 915-923.

Research output: Contribution to journalArticle

D'Arena, G, Rossi, G, Minervini, MM, Savino, L, D'Auria, F, Laurenti, L, Del Principe, MI, Deaglio, S, Biagi, A, De Martino, L, De Feo, V, Statuto, T, Musto, P & Del Poeta, G 2011, 'Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis', International Journal of Immunopathology and Pharmacology, vol. 24, no. 4, pp. 915-923.
D'Arena, Giovanni ; Rossi, G. ; Minervini, M. M. ; Savino, L. ; D'Auria, F. ; Laurenti, L. ; Del Principe, M. I. ; Deaglio, S. ; Biagi, A. ; De Martino, L. ; De Feo, V. ; Statuto, T. ; Musto, P. ; Del Poeta, G. / Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis. In: International Journal of Immunopathology and Pharmacology. 2011 ; Vol. 24, No. 4. pp. 915-923.
@article{a9ca3b5481d44d03afc06e4c53bf011e,
title = "Circulating regulatory T cells in {"}clinical{"} monoclonal B-cell lymphocytosis",
abstract = "Regulatory T-cells (Tregs) constitute a small subset of cells involved in antitumour immunity and are generally increased in patients with chronic lymphocytic leukemia (CLL). No data is available on Tregs in monoclonal B-cell lymphocytosis (MBL), a disease entity characterized by less than 5000/μL circulating clonal B-cells in absence of other features of lymphoproliferative disorders. We used multicolour flow cytometry to evaluate the number of circulating Tregs in 56 patients with {"}clinical{"} MBL, 74 patients with previously untreated CLL and 40 healthy subjects. MBL patients showed a lower absolute number of Tregs, compared to CLL patients, but slightly higher than controls. Moreover, the absolute cell number of Tregs directly correlated both with more advanced Rai/Binet clinical stages and peripheral blood B-cell lymphocytosis. Of note, the absolute number of Tregs was found lower in MBL patients than in CLL patients staged as 0/A Rai/Binet. The study showed that Tregs increase gradually from normal subjects to {"}clinical{"} MBL patients and are significantly higher in CLL patients as compared to MBL patients. Moreover, a significant direct relationship was found between higher Treg values and a higher tumor burden expressed by B-lymphocytosis or more advanced clinical stages. In light of this data, MBL seems to be a preliminary phase preceding CLL. The progressive increase of Treg numbers might contribute both to the clinical evolution of MBL to overt CLL and to CLL progression.",
keywords = "Chronic lymphocytic leukemia, Monoclonal B-cell lymphocytosis, Regulatory T cells",
author = "Giovanni D'Arena and G. Rossi and Minervini, {M. M.} and L. Savino and F. D'Auria and L. Laurenti and {Del Principe}, {M. I.} and S. Deaglio and A. Biagi and {De Martino}, L. and {De Feo}, V. and T. Statuto and P. Musto and {Del Poeta}, G.",
year = "2011",
month = "10",
language = "English",
volume = "24",
pages = "915--923",
journal = "International Journal of Immunopathology and Pharmacology",
issn = "0394-6320",
publisher = "Biomedical Research Press s.a.s.",
number = "4",

}

TY - JOUR

T1 - Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis

AU - D'Arena, Giovanni

AU - Rossi, G.

AU - Minervini, M. M.

AU - Savino, L.

AU - D'Auria, F.

AU - Laurenti, L.

AU - Del Principe, M. I.

AU - Deaglio, S.

AU - Biagi, A.

AU - De Martino, L.

AU - De Feo, V.

AU - Statuto, T.

AU - Musto, P.

AU - Del Poeta, G.

PY - 2011/10

Y1 - 2011/10

N2 - Regulatory T-cells (Tregs) constitute a small subset of cells involved in antitumour immunity and are generally increased in patients with chronic lymphocytic leukemia (CLL). No data is available on Tregs in monoclonal B-cell lymphocytosis (MBL), a disease entity characterized by less than 5000/μL circulating clonal B-cells in absence of other features of lymphoproliferative disorders. We used multicolour flow cytometry to evaluate the number of circulating Tregs in 56 patients with "clinical" MBL, 74 patients with previously untreated CLL and 40 healthy subjects. MBL patients showed a lower absolute number of Tregs, compared to CLL patients, but slightly higher than controls. Moreover, the absolute cell number of Tregs directly correlated both with more advanced Rai/Binet clinical stages and peripheral blood B-cell lymphocytosis. Of note, the absolute number of Tregs was found lower in MBL patients than in CLL patients staged as 0/A Rai/Binet. The study showed that Tregs increase gradually from normal subjects to "clinical" MBL patients and are significantly higher in CLL patients as compared to MBL patients. Moreover, a significant direct relationship was found between higher Treg values and a higher tumor burden expressed by B-lymphocytosis or more advanced clinical stages. In light of this data, MBL seems to be a preliminary phase preceding CLL. The progressive increase of Treg numbers might contribute both to the clinical evolution of MBL to overt CLL and to CLL progression.

AB - Regulatory T-cells (Tregs) constitute a small subset of cells involved in antitumour immunity and are generally increased in patients with chronic lymphocytic leukemia (CLL). No data is available on Tregs in monoclonal B-cell lymphocytosis (MBL), a disease entity characterized by less than 5000/μL circulating clonal B-cells in absence of other features of lymphoproliferative disorders. We used multicolour flow cytometry to evaluate the number of circulating Tregs in 56 patients with "clinical" MBL, 74 patients with previously untreated CLL and 40 healthy subjects. MBL patients showed a lower absolute number of Tregs, compared to CLL patients, but slightly higher than controls. Moreover, the absolute cell number of Tregs directly correlated both with more advanced Rai/Binet clinical stages and peripheral blood B-cell lymphocytosis. Of note, the absolute number of Tregs was found lower in MBL patients than in CLL patients staged as 0/A Rai/Binet. The study showed that Tregs increase gradually from normal subjects to "clinical" MBL patients and are significantly higher in CLL patients as compared to MBL patients. Moreover, a significant direct relationship was found between higher Treg values and a higher tumor burden expressed by B-lymphocytosis or more advanced clinical stages. In light of this data, MBL seems to be a preliminary phase preceding CLL. The progressive increase of Treg numbers might contribute both to the clinical evolution of MBL to overt CLL and to CLL progression.

KW - Chronic lymphocytic leukemia

KW - Monoclonal B-cell lymphocytosis

KW - Regulatory T cells

UR - http://www.scopus.com/inward/record.url?scp=84856577660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856577660&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 915

EP - 923

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

SN - 0394-6320

IS - 4

ER -